Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05494450 · ClinicalTrials.gov registry record · NA
An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds
A NA study, sponsored by Molnlycke Health Care AB.
- Terminated
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05494450 is a NA study that was terminated before completion, run by Molnlycke Health Care AB. The registered enrollment target is 46 participants.
The verdict
NCT05494450, a NA study, was terminated before completion, sponsored by Molnlycke Health Care AB.
- TERMINATED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
An open, non-comparative, multicenter investigation to evaluate the safety and performance of Exufiber Ag+, a gelling fiber silver dressing, when used in medium to high exuding chronic wounds
Interventions
- DEVICE ExufiberAG+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2022-11-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05494450
The ClinicalTrials.gov registry entry for NCT05494450 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExufiberAG+ is the first listed.
NCT05494450 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05494450 about?
NCT05494450 is a clinical study titled "An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver Dressing, When Used in Medium to High Exuding Chronic Wounds". An open, non-comparative, multicenter investigation to evaluate the safety and performance of Exufiber Ag+, a gelling fiber silver dressing, when used in medium to high exuding chronic wounds
What is the current status of trial NCT05494450?
This trial is currently terminated. It is a NA study. The enrollment target is 46 participants. The study started on 2022-01-01. Estimated completion is 2022-11-29.
What interventions are being tested in trial NCT05494450?
The interventions under investigation include: ExufiberAG+ (DEVICE).
Who is sponsoring clinical trial NCT05494450?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.